Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MMP8 | P22894 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MC4R | P32245 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA3 | P07451 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA6 | P23280 | 1/20 | 0.51 |
| ▸ | CA5A | P35218 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21538610 | 0.85 | KMT2A (0.63) | KMT2AMMP8MMEMEN1ALDH1A1 | |
| SCHEMBL21538582 | 0.85 | KMT2A (0.63) | KMT2AMMP8MMEMEN1ALDH1A1 | |
| SCHEMBL30476096 | 0.83 | KMT2A (0.57) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL12240252 | 0.83 | KMT2A (0.57) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL30175033 | 0.83 | KMT2A (0.55) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL10534524 | 0.82 | KMT2A (0.59) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL714386 | 0.82 | KMT2A (0.59) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL6522964 | 0.82 | KMT2A (0.59) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL714385 | 0.82 | KMT2A (0.59) | KMT2AMMP8GAAMMEMEN1 | |
| SCHEMBL10954350 | 0.81 | KMT2A (0.61) | KMT2AGAAMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980285-A | Process for producing purified dichloroacetic acid | 住友化学株式会社 | 2024-05-03 | — | — | CN | claimed |
| US-4493727-A | DICHLOROACETYL COMPOUND | ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) | 1985-01-15 | — | — | US | claimed |
| CN-117980285-A | Process for producing purified dichloroacetic acid | 住友化学株式会社 | 2024-05-03 | — | — | CN | disclosed |
| EP-2484663-B1 | PHENOLIC COMPOUND AND RECORDING MATERIAL | NIPPON SODA CO (JP) | 2019-07-17 | — | — | EP | disclosed |
| US-8431513-B2 | Phenolic compound and recording material | NIPPON SODA CO., LTD. (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120204763-A1 | PHENOLIC COMPOUND AND RECORDING MATERIAL | NIPPON SODA CO., LTD. | 2012-08-16 | — | — | US | disclosed |
| EP-2484663-A1 | PHENOLIC COMPOUND AND RECORDING MATERIAL | Nippon Soda Co., Ltd. (JP) | 2012-08-08 | — | — | EP | disclosed |
| EP-0641204-B1 | 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDS | MERCK & CO INC (US) | 2000-08-16 | — | — | EP | disclosed |
| US-5693809-A | PREGNANES FOR TREATING ALOPECIA, ACNE AND SKIN DISORDER | MERCK & CO., INC. (US) | 1997-12-02 | — | — | US | disclosed |
| US-5536727-A | TREATMENT OF HYPERANDROGENIC DISEASES | MERCK & CO., INC. (US) | 1996-07-16 | — | — | US | disclosed |
| EP-0641204-A4 | 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDS. | MERCK & CO INC (US) | 1995-08-23 | — | — | EP | disclosed |
| EP-0641204-A1 | 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDS | MERCK & CO. INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| WO-1993023040-A1 | 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1993023039-A1 | SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| US-4493727-A | DICHLOROACETYL COMPOUND | ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) | 1985-01-15 | — | — | US | disclosed |
| US-4033756-A | PROTECTIVE COATINGS | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
| US-3982923-A | THIOCARBAMATE | STAUFFER CHEMICAL COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3981716-A | CORN, WEEDS | STAUFFER CHEMICAL COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120204763-A1 | PHENOLIC COMPOUND AND RECORDING MATERIAL | OR10J3, OR51E2, H1-4 | KMT2A 1509/4885MMP8 3218/4885GAA 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.